Of the, the 1088 MAb was the most potent, with an IC50 in the same order of magnitude as the positive control antibodies directed to the V3 domain name (1026) and the CD4 binding site (b12)
Of the, the 1088 MAb was the most potent, with an IC50 in the same order of magnitude as the positive control antibodies directed to the V3 domain name (1026)…